Indian equity markets staged a strong recovery on Monday, with Nifty 50 closing at 24,211.00, up 4.10 points (+0.02%) after a volatile session that saw the index test its psychologically important support at 24,000. According to MarketSmith India, the recovery was heavily boosted by Nifty IT's stellar performance at +3.59%, led by heavyweights like TCS and HCL Tech ahead of earnings, which successfully neutralized macroeconomic headwinds from a 3% surge in global Brent crude prices following escalating US-Iran hostilities. Market breadth remained modestly positive with 1,776 stocks advancing against 1,557 declining, indicating selective buying despite the subdued performance of the headline index. The rally was further supported by strong performance in Media (+2.09%) and Consumer Durables (+1.15%), while FMCG (-1.02%), Metal (-0.69%), Healthcare, Pharma, and Realty indices ended lower, limiting broader market gains.
MarketSmith India has issued two new stock recommendations for today, 15 July. Orchid Pharma Limited is recommended as a buy at current price of ₹1,055, with a target price of ₹1,200 in two to three months and stop loss at ₹990. The recommendation is based on the company's strong focus on antibiotics APIs, growing formulations business, export market opportunities, USFDA-approved manufacturing facilities, backing from experienced promoter group, capacity utilization improvement potential, product pipeline expansion, benefit from China+1 sourcing trend, increasing domestic pharma demand, and turnaround in financial performance. Key metrics show P/E ratio of 185.20 with 52-week high of ₹1,106.95 and trading volume of ₹83.22 crore. Multi Commodity Exchange of India Limited is also recommended as a buy at current price of ₹2,891, with a target price of ₹3,290 in two to three months and stop loss at ₹2,700. The recommendation highlights India's leading commodity exchange status, strong market leadership, asset-light business model, high operating margins, growth in commodity trading volumes, new product launches support growth, rising participation from retail investors, technology platform improvements, strong cash generation, and favorable long-term commodity market outlook.
Indian equity markets ended lower on Tuesday, with selling pressure persisting through the session amid weak global sentiment and rising geopolitical concerns. Nifty 50 declined 158.95 points (-0.66%) to close at 24,052.05, after trading in a range of 24,023.70–24,157.10, while BSE Sensex dropped 561 points (-0.72%) to finish at 77,054.94. The decline was weighed down by escalating West Asia conflicts and a sharp 4% surge in Brent crude to $87 per barrel. Sectoral performance was largely negative, with Nifty Realty (-1.97%), PSU Bank (-1.80%), Auto (-1.61%), Financial Services (-1.08%), and IT (-1.00%) leading the declines. On the other hand, Pharma (+1.03%), Healthcare (+0.89%), and Metal (+0.61%) outperformed. Market breadth remained decisively bearish, recording 1,022 advances against 2,278 declines across the broader market, reflecting broad-based selling pressure.
From a technical perspective, Nifty 50 continues to exhibit a cautious bias after closing at 24,052.05, with the index forming a small bearish candle after failing to sustain the recent recovery. The 14-day RSI has eased to around 52, slipping below its signal line after recently moving into bullish territory, indicating that positive momentum has moderated. However, the oscillator remains above the neutral 50 mark, implying that the broader trend has not turned outright bearish. The MACD remains in positive territory with the MACD line above the signal line, though the histogram has narrowed considerably, highlighting waning bullish momentum. The index is currently trading near a crucial support zone at 23,800, which will be closely monitored, while Nifty Bank opened at 57,832.55 and settled at 57,462.30, down 669.15 points (-1.15%). A decisive move above 24,300 would be required to improve near-term sentiment and signal a recovery in market momentum, while a breakdown below 23,800 could intensify selling pressure.
